510(k) OpGen Receives FDA Clearance for AMR Panel, Prelim Q3 Revenues Up 9 Percent The firm's Acuitas AMR Gene Panel tests for 28 genetic AMR markers in isolated bacterial colonies from 26 different pathogens. NYU Langone Health Gets FDA Clearance for Solid Tumor Gene Sequencing Test The test uses next-generation sequencing to detect cancer-linked mutations in 607 genes to help guide patient treatment. FDA Clears Zymo Research Coronavirus Sample Collection Device Zymo Research previously received CE-IVD marking for the collection device, which enables the transport and storage of SARS-CoV-2 RNA at ambient temperatures. Luminex Nabs $11.3M From BARDA to Develop Test for SARS-CoV-2, Flu, RSV The firm said it intends to apply to obtain FDA Emergency Use Authorization and 510(k) clearance for a panel that detects respiratory targets in a single test. Roche Receives FDA Clearance for Cobas BKV Test for Use With Urine Samples The test was previously cleared by the FDA for use with ethylenediaminetetraacetic acid plasma samples to manage BK virus in transplant patients. Dec 9, 2020 Mesa Biotech Receives 510(k) Clearance, CLIA Waiver for Strep A Molecular Point-of-Care Test Oct 14, 2020 OpGen Provides Additional Info to FDA on Antimicrobial Resistance Gene Panel Sep 8, 2020 FDA Clears DiaSorin Test for Influenza, RSV Sep 8, 2020 Roche BK Virus Test Garners FDA Clearance Sep 1, 2020 Immunexpress, Biocartis to Roll Out Sepsis Test in Europe Ahead of Planned US Launch Premium Aug 18, 2020 23andMe Garners FDA Clearance for CYP2C19 PGx Test Report Apr 30, 2020 FDA Provides Second Clearance for Binx MDx Platform Apr 1, 2020 FDA Proposes Reclassification of HCV RNA, Antibody Tests Jan 31, 2020 Translational Software to Submit PGx Software Platform for 510(k) Clearance Premium Jan 8, 2020 Applied BioCode Receives FDA Clearance for Syndromic Respiratory Pathogen Panel Dec 20, 2019 FDA Clears Curetis Lower Respiratory Tract Infections Panel Dec 17, 2019 FDA Clears DiaSorin Molecular VZV Test Nov 19, 2019 Rheonix Submits MDx System, Triplex Sexually Transmitted Infections Test to FDA Nov 12, 2019 FDA Clears NantHealth Tumor-Normal Whole-Exome Test Oct 1, 2019 FDA Clears Luminex Aries MRSA Assay Sep 12, 2019 Applied BioCode Submits Respiratory Pathogen Panel to FDA Jun 12, 2019 FDA Clears Roche Extraction Platform For Use With Applied BioCode GI Pathogen Panel, System Jun 6, 2019 Akonni Bio Obtains FDA 510(k) Clearance for TruDiagnosis MDx System, PGx Test Apr 30, 2019 InDevR Gets FDA 510(k) Clearance for Influenza Assay Apr 15, 2019 GenMark Diagnostics Obtains FDA Clearance for Gram-Negative Sepsis Panel Load More Breaking News Variant Identified in Amish Population Appears to Protect From Cardiovascular Disease Danaher Prices $1B Offering of Senior Notes Discovery Life Sciences Acquires Contract Research Firm In Vitro ADMET Laboratories Audere Gets FDA Emergency Use Authorization for SARS-CoV-2 At-Home Sample Collection Kit GenomeWeb Index Falls 6 Percent in November as Emergence of Omicron Spooks Markets Sequencing-Based MRD Detection in Bone Marrow May Predict ALL Relapse After CAR T-Cell Therapy The Scan Science Confidence Boost The New York Times reports that a new poll finds trust in science and scientists has increased with the COVID-19 pandemic. Appeal and Funds Some grant applications denied funding due to an Australian Research Council rule change have now been funded following an appeal, the Guardian reports. Surveillance for Variants Vox writes that the detection of the Omicron SARS-CoV-2 variant highlights the need for improved viral genomic surveillance. Nature Papers Examine Taxonomic Gaps in Plant Sequencing, SARS-CoV-2-Human Interactome In Nature this week: plant genome sequencing dominated by affluent countries, and more.